Want to join the conversation?
$ATU now expects FY17 sales of $1.075-1.125Bil, reflecting core sales decline of 2-6%. $ATU sees EPS excluding restructuring charges of $1.00-1.20, reflecting lower sales and higher effective tax rate, offset by benefit of cost reduction actions. $ATU sees 1Q17 sales of $260-270MM on a 14-16% core sales decline and EPS of $0.14-0.19.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)